Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H9942

Longevity Health Plan

1,113 members

5

0.0 vs 2026Above the 4 star line

Ask about H9942

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

5 · At 5★

Medication Adherence for Hypertension (RAS antagonists)

5 · At 5★

Medication Adherence for Cholesterol (Statins)

5 · At 5★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan50.07
C28 Members Choosing to Leave the Plan56%
C17 Plan All-Cause Readmissions3x49%
C02 Colorectal Cancer Screening582%
C13 Kidney Health Evaluation for Patients with Diabetes587%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions592%
C32 Call Center – Foreign Language Interpreter and TTY Availability394%
C11 Diabetes Care – Eye Exam598%
C12 Diabetes Care – Blood Sugar Controlled3x598%
C07 Special Needs Plan (SNP) Care Management5100%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.